Pharmafile Logo
Pharmafocus logo
Advanced Search
VBLOC image

FDA approves novel obesity device

January 16, 2015
Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2

The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …

News
philippe_goupit_

MedDay appoints senior head from Sanofi

January 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippe Goupit, Sanofi, medday

Paris-based biotech MedDay has appointed Philippe Goupit as an independent non-executive director. Goupit was until recently the vice president of …

Appointment

CDF chair: more treatment reviews to come

January 16, 2015
Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

News
Olysio image

Janssen privy to new pricing scheme and see NICE nod

January 16, 2015
Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir

Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …

News
Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

News
Strivrerdi image

Boehringer complaint ruled out by PMCPA

January 15, 2015
Medical Communications, Sales and Marketing ABPI, Boehringer, COPD, PMCPA, Striverdi, olodaterol

A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …

News
BI image

Sanofi and Boehringer partner on biologics manufacturing

January 15, 2015
Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology

Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …

News
data report

Sharing trial data should be ‘expected norm’ says US think-tank

January 15, 2015
Medical Communications, Research and Development, Sales and Marketing FDA, Goldacre, Institute of Medicine, clinical trials, transparency

Clinical trial data is in the public interest and should be shared no less than 30 days following regulatory approval …

News

NICE releases reflux disease guidelines

January 15, 2015
Sales and Marketing NHS, NICE, UK, gor, gord, h2ra

NICE has released new guidelines providing doctors with advice on how to treat gastro-oesophageal reflux disease (GORD) in young people. …

News
andy_kinnear_hscic

HSCIC appoints new specialist

January 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HSCIC, andy kinnear

The Health and Social Care Information Centre (HSCIC) has appointed Andy Kinnear as a specialist. He will join the organisation …

Appointment
Brilinta image

AstraZeneca’s troubled Brilinta gets welcome lift

January 14, 2015
Sales and Marketing AstraZeneca, Brilinta, FDA, US Department of Justice, acute coronary syndrome, ticagrelor

AstraZeneca has reported positive primary endpoint results for its anti-clogging drug Brilinta to treat patients who have had a heart …

News
Biogen Idec image

Biogen Idec buys Convergence

January 14, 2015
Sales and Marketing BG00010, Biogen IDEC, CNV1014802, Colombia University Medical Center, Convergence, Neublastin

Biogen Idec is to acquire independent UK-based Convergence Pharmaceuticals to strengthen its pipeline of drugs for pain management in a …

News

BMS Opdivo trial scores early goal

January 14, 2015
Research and Development, Sales and Marketing BMS, Merck, cancer nsclc, keytruda, nivolumab, opdivo

A late-stage trial of Bristol-Myers Squibb’s lung cancer drug Opdivo has been stopped early after showing promising results – but …

News
eliot_forster_immunocore_portrait_2

Immunocore names chief executive

January 14, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eliot Forster, immunocore

Oxford-based biotec Immunocore has announced the appointment of Dr Eliot Forster as its chief executive with immediate effect. Forster takes …

Appointment
Lilly image

Lilly, BMS and Merck unite for cancer trials

January 13, 2015
Research and Development, Sales and Marketing BMS, Cancer, Galunisertib, Merck, NSCLC, keytruda, lilly, oncology, opdivo

Lilly will test some of its compounds in combination with rival cancer drugs from Bristol-Myers Squibb and Merck, the companies …

News
Roche image

Roche teams up to tackle antibiotics resistance

January 13, 2015
Research and Development, Sales and Marketing Antibiotics, Fedora, Meiji, OP0595, Roche, Teixobactin

Roche is to collaborate with Japan-based pharma firm Meiji and Canadian Fedora – two companies specialising in the production of …

News

New UCB chief starts and expands team

January 13, 2015
Sales and Marketing Cimzia, Jean-Christophe Tellier, Neupro, UCB, roch deliveux, vimpat

New UCB chief executive Jean-Christophe Tellier who succeeded Roch Doliveux this year has also welcomed three new members to the …

News
AMRI image

AMRI buys two Aptuit facilities

January 13, 2015
Manufacturing and Production AMRI, Aptuit, cedarburg, glasgow, oso

Contract research and manufacturing firm AMRI has acquired two businesses from pharmaceutical services company Aptuit in a $60 million deal. …

News
greg_weaver

Oryzon Genomics names CFO and executive VP

January 13, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gregory Weaver, Oryzon genomics

Spanish clinical stage biopharma firm Oryzon Genomics has appointed Gregory Weaver as its executive vice president and chief financial officer. …

Appointment
dendreon image

Another NICE no for Dendreon cancer drug

January 13, 2015
Sales and Marketing Cancer, Dendreon, FDA, NHS, NICE, Provenge, sipuleucel-T

Dendreon has seen its prostate cancer treatment for people whose disease has spread and who are not yet suitable for …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026